These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25203310)

  • 1. Urine and serum concentrations of Cytokeratin 19 in preeclampsia.
    Kuessel L; Wild J; Haslacher H; Perkmann T; Ristl R; Zeisler H; Schmid M
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():311-5. PubMed ID: 25203310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study.
    Kuessel L; Zeisler H; Ristl R; Binder J; Pateisky P; Schmid M; Marschalek J; Perkmann T; Haslacher H; Husslein H
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):339. PubMed ID: 27809797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of radom spot albuminuria to creatinine ratio in women with preeclampsia].
    Gao YF; Huang QT; Zhong M; Wang Y; Wang W; Wang ZJ; Leng LZ; Yu YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):166-70. PubMed ID: 22781065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
    Guo XG; Long JJ
    Tumour Biol; 2016 Oct; 37(10):14329-14330. PubMed ID: 27448817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of CA-125 in normal and preeclamptic pregnancies.
    Ozat M; Kanat-Pektas M; Yenicesu O; Gungor T; Danisman N; Mollamahmutoglu L
    Arch Gynecol Obstet; 2011 Sep; 284(3):607-12. PubMed ID: 21046132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21-1) for bladder cancer: a systematic review and meta-analysis.
    Huang YL; Chen J; Yan W; Zang D; Qin Q; Deng AM
    Tumour Biol; 2015 May; 36(5):3137-45. PubMed ID: 25854170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia.
    Shahbazian N; Hosseini-Asl F
    Iran J Kidney Dis; 2008 Jul; 2(3):127-31. PubMed ID: 19377225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random urine protein creatinine ratio as a preadmission test in hypertensive pregnancies with urinary protein creatinine ratio.
    Eslamian L; Behnam F; Tehrani ZF; Jamal A; Marsoosi V
    Acta Med Iran; 2011; 49(2):81-4. PubMed ID: 21598214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
    Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cut-off values for CYFRA 21-1 expression in NSCLC patients depend on the presence of benign pulmonary diseases.
    Xu RH; Liao CZ; Luo Y; Xu WL; Li K; Chen JX; Huang YF; Chen YC; Zhu L; Yuan WB
    Clin Chim Acta; 2015 Feb; 440():188-92. PubMed ID: 25304744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 24-hour urinary protein and protein-to-creatinine ratio in women with preeclampsia.
    Kayatas S; Erdogdu E; Cakar E; Yılmazer V; Arınkan SA; Dayıcıoglu VE
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):368-71. PubMed ID: 23928475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia.
    Son GH; Kwon JY; Lee S; Park J; Kim YJ; Yun B; Park JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):139-44. PubMed ID: 23116596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal Complement Activation in Preeclampsia.
    Burwick RM; Velásquez JA; Valencia CM; Gutiérrez-Marín J; Edna-Estrada F; Silva JL; Trujillo-Otálvaro J; Vargas-Rodríguez J; Bernal Y; Quintero A; Rincón M; Tolosa JE
    Obstet Gynecol; 2018 Dec; 132(6):1477-1485. PubMed ID: 30399106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia.
    Hefler LA; Tempfer CB; Bancher-Todesca D; Schatten C; Husslein P; Heinze G; Gregg AR
    J Soc Gynecol Investig; 2001; 8(3):169-73. PubMed ID: 11390252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental expression and serum concentrations of cytokeratin 19 in preeclampsia.
    Tempfer CB; Bancher-Todesca D; Zeisler H; Schatten C; Husslein P; Gregg AR
    Obstet Gynecol; 2000 May; 95(5):677-82. PubMed ID: 10775728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased inflammatory response and imbalance in blood and urinary oxidant-antioxidant status in South Indian women with gestational hypertension and preeclampsia.
    Babu MS; Bobby Z; Habeebullah S
    Clin Biochem; 2012 Jul; 45(10-11):835-8. PubMed ID: 22561001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.
    Okamura K; Takayama K; Izumi M; Harada T; Furuyama K; Nakanishi Y
    Lung Cancer; 2013 Apr; 80(1):45-9. PubMed ID: 23352032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung.
    Park SY; Lee JG; Kim J; Park Y; Lee SK; Bae MK; Lee CY; Kim DJ; Chung KY
    Lung Cancer; 2013 Feb; 79(2):156-60. PubMed ID: 23206831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
    Muley T; He Y; Rolny V; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Meister M; Herth FJ; Dayyani F
    Lung Cancer; 2019 Apr; 130():194-200. PubMed ID: 30885344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.